NYSE:TEVA
Teva Pharmaceutical Industries Limited Stock News
$14.05
-0.0500 (-0.355%)
At Close: Apr 30, 2024
Down 30% in a Day, Is Catalyst Pharmaceuticals Doomed?
02:22pm, Thursday, 26'th Jan 2023 The Motley Fool
Things aren't as bad as they might seem.
6 Great Stocks to Buy in 2023 and Hold Forever
11:31am, Thursday, 26'th Jan 2023 The Motley Fool
I own all six great businesses and don't plan to sell a single share.
6 Great Stocks to Buy in 2023 and Hold Forever
06:31am, Thursday, 26'th Jan 2023
I own all six great businesses and don't plan to sell a single share.
Nasdaq Bear Market: 3 Screaming Bargains That Can Double Your Money by 2025
10:21am, Wednesday, 25'th Jan 2023 The Motley Fool
A 33% plunge in the Nasdaq Composite is the opportune time to scoop up these exceptional deals.
Nasdaq Bear Market: 3 Screaming Bargains That Can Double Your Money by 2025
05:21am, Wednesday, 25'th Jan 2023
A 33% plunge in the Nasdaq Composite is the opportune time to scoop up these exceptional deals.
Catalyst (CPRX) Down on TEVA's FDA Filing for Firdapse Generic
05:26pm, Tuesday, 24'th Jan 2023 Zacks Investment Research
Catalyst Pharmaceuticals (CPRX) receives a notice letter stating that Teva Pharmaceuticals has filed an application to the FDA seeking approval for a generic version of Firdapse.
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023
03:01pm, Thursday, 19'th Jan 2023 Benzinga
Upgrades
For Coeur Mining Inc (NYSE:CDE), Canaccord Genuity upgraded the previous rating of Sell to Hold. In the third quarter, Coeur Mining showed an EPS of $0.16, compared to $0.01 from the year-ago
Analyst Ratings for Teva Pharmaceutical Indus
02:01pm, Thursday, 19'th Jan 2023 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Teva Pharmaceutical Indus (NYSE:TEVA) stock. These analysts are typically employed by large Wall Street banks and tasked with underst
Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday
12:57pm, Thursday, 19'th Jan 2023 Benzinga
JP Morgan cut the price target for Apple Inc. (NASDAQ: AAPL) from $190 to $180. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Apple shares fell 1.1% to $133.70 in pre-market tr
3 Dirt Cheap Stocks to Buy in January
11:15am, Saturday, 14'th Jan 2023 The Motley Fool
Bargains can easily be found as the new year gets underway.
3 Dirt Cheap Stocks to Buy in January
06:15am, Saturday, 14'th Jan 2023
Bargains can easily be found as the new year gets underway.
If You Invested $1,000 in Novavax In 2020, This Is How Much You Would Have Today
10:15am, Friday, 13'th Jan 2023 The Motley Fool
The stock has gone on a wild ride over the past few years.
Teva Pharmaceutical Industries Ltd. (TEVA) Presents at 41st Annual J.P.
03:45pm, Wednesday, 11'th Jan 2023
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA ) 41st Annual J.P.
TEVA Shares Rise on Broad Support for Opioids Settlement
03:03pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
With the required participation from states and local governments, TEVA can now move forward with the nationwide settlement.
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Jumps 5.5%: Will It Continue to Soar?
01:19pm, Monday, 09'th Jan 2023 Zacks Investment Research
Teva Pharmaceutical Industries Ltd. (TEVA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that the
